COVID-19 infection. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: patients in this group use 5 milliliters of natural product (brand name: Mocozift) produced in Behdane Baran pharmaceutical company, three times a day for five days
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age older than 18 years Confirmed COVID-19 infection using PCR test Prescription of Remdesivir for outpatient use Avoiding use of other traditional medicine or supplements during the trial signing the informed consent form
Exclusion criteria
Exclusion criteria: Participating in other clinical trials History of hypersensitivity reactions to natural or herbal medicines
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of dyspnea severity according to Modified Medical Research Council Dyspnea Scale. Timepoint: One day before medicinal intervention and fifth day of intervention. Method of measurement: Modified Medical Research Council Dyspnea Scale.;Cough severity. Timepoint: One day before medicinal intervention and fifth day of intervention. Method of measurement: Cough visual analogue scale.;Appetite. Timepoint: One day before medicinal intervention and fifth day of intervention. Method of measurement: Simplified Nutritional Appetite Questionnaire (SNAQ).;Fatigue severity. Timepoint: One day before medicinal intervention and fifth day of intervention. Method of measurement: Fatigue Severity Scale (FSS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBabak Daneshfard
Shahid Beheshti University of Medical Sciences
Outcome results
None listed